[31] Relapse of CMV infection after treatment with ganciclovir is more likely to occur if ganciclovir is discontinued while viral replication is ongoing. Therefore, it has been recommended to ...

BioViva’s journey in gene therapy began with its use of an adeno-associated virus (AAV ... in the treatment of complex disorders,” said Church. BioViva’s early-stage CMV projects are ...

Takeda (NYSE:TAK) said Chinese regulators have approved its drug Livtencity for the treatment of adults with post-transplant CMV disease ... cytomegalovirus infection or disease that is refractory ...